SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-058716
Filing Date
2023-12-15
Accepted
2023-12-15 08:22:58
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7972
  Complete submission text file 0001209191-23-058716.txt   9507
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IN8BIO, INC. EMPIRE STATE BUILDING, SUITE 5330 NEW YORK NY 10118
Business Address
Rochlin Kate (Reporting) CIK: 0001898521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 231488838